Silano Vittorio, Bolognesi Claudia, Castle Laurence, Cravedi Jean-Pierre, Fowler Paul, Franz Roland, Grob Konrad, Gürtler Rainer, Husøy Trine, Kärenlampi Sirpa, Mennes Wim, Milana Maria Rosaria, Penninks André, Smith Andrew, de Fátima Tavares Poças Maria, Tlustos Christina, Wölfle Detlef, Zorn Holger, Zugravu Corina-Aurelia, Chesson Andrew, Glandorf Boet, Hermann Lieve, Jany Klaus-Dieter, Marcon Francesca, Želježic Davor, Andryszkiewicz Magdalena, Liu Yi, Engel Karl-Heinz
EFSA J. 2017 May 10;15(5):e04754. doi: 10.2903/j.efsa.2017.4754. eCollection 2017 May.
The food enzyme considered in this opinion is a β-amylase (EC 3.2.1.2), obtained from the grain of wheat ( spp.) by Roquette (France). The β-amylase is intended to be used in starch processing for production of glucose syrups containing maltose to be used as a food ingredient. Since the presence of residual amounts of total organic solids (TOS) in glucose syrups after filtration and purification during starch processing is negligible, no dietary exposure was calculated. As the food enzyme is derived from edible parts of wheat, no toxicological tests are required. Wheat is known as a gluten-containing cereal. However, the gluten content of the food enzyme was shown to be below the limit of quantification of the applied analytical method and well below the threshold value of 20 mg/kg for 'gluten-free' products. Furthermore, the potential allergenicity was evaluated by searching for similarity between the amino acid sequence of the β-amylase and the sequences of known food allergens; no match was found. Although β-amylase from wheat is described as a potential occupational respiratory allergen, and oral wheat challenges in wheat allergic patients may result in clinical symptoms, the enzyme and the low levels of other wheat proteins will be removed from the final food ingredients through a downstream purification process. Based on the origin of the food enzyme from edible parts of grain, the manufacturing process, and the compositional and biochemical data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.
本意见所考虑的食品酶是一种β-淀粉酶(EC 3.2.1.2),由罗盖特公司(法国)从小麦( spp.)的谷物中获得。该β-淀粉酶拟用于淀粉加工,以生产含麦芽糖的葡萄糖浆,用作食品配料。由于淀粉加工过程中过滤和纯化后葡萄糖浆中总有机固体(TOS)的残留量可忽略不计,因此未计算膳食暴露量。由于该食品酶源自小麦的可食用部分,则无需进行毒理学测试。小麦是一种含麸质的谷物。然而,该食品酶的麸质含量低于所采用分析方法的定量限,且远低于“无麸质”产品20mg/kg的阈值。此外,通过搜索β-淀粉酶的氨基酸序列与已知食物过敏原序列之间的相似性来评估其潜在致敏性;未发现匹配情况。尽管来自小麦的β-淀粉酶被描述为一种潜在的职业性呼吸道过敏原,且小麦过敏患者进行口服小麦激发试验可能会出现临床症状,但该酶和其他低水平的小麦蛋白将通过下游纯化过程从最终食品配料中去除。基于该食品酶源自谷物可食用部分、制造工艺以及所提供的成分和生化数据,专家小组得出结论,在预期使用条件下,这种食品酶不会引发安全问题。